120 related articles for article (PubMed ID: 396063)
1. Haemodynamic profile of angiotensin II antagonism in essential hypertensive patients.
Hunyor SN; Larkin H; Rowe J
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():119s-121s. PubMed ID: 396063
[TBL] [Abstract][Full Text] [Related]
2. [Hemodynamic changes after angiotensin II blockade by saralasin (author's transl)].
Liebau G; Beyer J; Larbig D; Schick K; Sekanina G; Hayduk K
Klin Wochenschr; 1977 Jul; 55(13):647-9. PubMed ID: 19645
[TBL] [Abstract][Full Text] [Related]
3. Effect of angiotensin-II blockade on systemic and hepatic haemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites.
Arroyo V; Bosch J; Mauri M; Ribera F; Navarro-López F; Rodés J
Eur J Clin Invest; 1981 Jun; 11(3):221-9. PubMed ID: 6791942
[TBL] [Abstract][Full Text] [Related]
4. Systemic hemodynamic and hormonal responses during angiotensin II blockade with saralasin.
Roos JC; Geyskes GG; Boer P; Dorhout Mees EJ
J Cardiovasc Pharmacol; 1981; 3(5):1106-15. PubMed ID: 6168855
[TBL] [Abstract][Full Text] [Related]
5. Effect of the angiotensin antagonist saralasin on hemodynamics in hypertensive non-uraemic chronic renal disease.
Brod J; Bahlmann J; Cachovan M; Hubrich W; Pretschner D
Nephron; 1980; 25(4):167-72. PubMed ID: 6990284
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II blockade during combined thiazide-beta-adrenoreceptor-blocker treatment.
Ibsen H; Leth A; McNair A; Giese J
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():123s-125s. PubMed ID: 396064
[TBL] [Abstract][Full Text] [Related]
7. Does the renin-angiotensin system maintain blood pressure in both hypertensive and normotensive subjects? A comparison of propranolol, saralasin and captopril.
MacGregor GA; Markandu ND; Roulston JE
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():145s-148s. PubMed ID: 396068
[No Abstract] [Full Text] [Related]
8. Angiotensin II blockade in normal subjects and essential hypertensive patients.
MacGregor GA; Dawes PM
Clin Sci Mol Med Suppl; 1976 Dec; 3():193s-196s. PubMed ID: 1071606
[TBL] [Abstract][Full Text] [Related]
9. Effects of angiotensin II blockade by saralasin in normal man.
Noth RH; Tan SY; Mulrow PJ
J Clin Endocrinol Metab; 1977 Jul; 45(1):10-5. PubMed ID: 874056
[TBL] [Abstract][Full Text] [Related]
10. [Hemodynamics, renin and aldosterone following angiotensin II blockade and sodium chloride deficiency in hypertensive subjects].
Beyer J; Liebau G; Steiner B; Schick K; Hayduk K
Verh Dtsch Ges Kreislaufforsch; 1977; 43():212-3. PubMed ID: 613577
[No Abstract] [Full Text] [Related]
11. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH
Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
[TBL] [Abstract][Full Text] [Related]
12. Haemodynamic effects of captopril in hypertensive patients: comparison with saralasin.
Fagard R; Amery A; Lijnen P; Reybrouck T
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():131s-134s. PubMed ID: 396066
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and pharmacodynamic studies of infusions with [Sar 1, Val5, Ala8] angiotensin II (saralasin).
Gless KH; Bönner G; Gram N; Mann JF; Helber A; Ganten D
Klin Wochenschr; 1978; 56 Suppl 1():97-105. PubMed ID: 732257
[TBL] [Abstract][Full Text] [Related]
14. Systemic and pulmonary hemodynamic effects of saralasin infusion in hypertension. Predictability of plasma renin status from hemodynamic changes.
Mookherjee S; Obeid A; Warner R; Anderson G; Eich R; Smulyan H
Am J Cardiol; 1978 Dec; 42(6):987-92. PubMed ID: 727149
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II blockade before and after marked sodium depletion in patients with hypertension.
Van Hoogdalem P; Donker AJ; Leenen FH
Clin Sci Mol Med; 1978 Jan; 54(1):75-83. PubMed ID: 620496
[TBL] [Abstract][Full Text] [Related]
16. Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients.
Case DB; Wallace JM; Keim HJ; Sealey JE; Laragh JH
Am J Med; 1976 May; 60(6):825-36. PubMed ID: 1020762
[TBL] [Abstract][Full Text] [Related]
17. Effects of 1-Sar-8-Ala-angiotensin II on systemic and pulmonary haemodynamics in hypertensive patients.
Fagard R; Amery A; Lijnen P; Reybrouck T; Joossens JV; Billiet L; Moerman E; De Schaepdryver A
Clin Exp Pharmacol Physiol; 1978; 5(5):457-64. PubMed ID: 729204
[No Abstract] [Full Text] [Related]
18. Effect of saralasin in hypertensive patients on chronic hemodialysis.
Lifschitz MD; Kirschenbaum MA; Rosenblatt SG; Gibney R
Ann Intern Med; 1978 Jan; 88(1):23-7. PubMed ID: 619754
[TBL] [Abstract][Full Text] [Related]
19. Renal vascular response to interruption of the renin-angiotensin system in normal man.
Hollenberg NK; Williams GH; Taub KJ; Ishikawa I; Brown C; Adams DF
Kidney Int; 1977 Oct; 12(4):285-93. PubMed ID: 599839
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II blockade in patients with essential hypertension.
MacGregor GA; Dawes PM
Aust N Z J Med; 1976 Aug; 6(3 Suppl):53-4. PubMed ID: 1071404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
